Korean Circ J.  2021 Jul;51(7):623-625. 10.4070/kcj.2021.0185.

Optimal Strategy of Hypertension Screening in a Nationwide Health Examination: Early and Periodic Blood Pressure Measurement

• Lee EM

• KMID: 2517491
• DOI: http://doi.org/10.4070/kcj.2021.0185

Reference

1. Kang SH, Kim SH, Cho JH, et al. Prevalence, awareness, treatment, and control of hypertension in Korea. Sci Rep. 2019; 9:10970. PMID: 31358791.

2. Kim HC, Cho SMJ, Lee H, et al. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021; 27:8–11. PMID: 33715619.

3. Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020; 324:1190–1200. PMID: 32902588.

4. Nguyen TP, Wright EP, Nguyen TT, et al. Cost-effectiveness analysis of screening for and managing identified hypertension for cardiovascular disease prevention in Vietnam. PLoS One. 2016; 11:e0155699. PMID: 27192051.

5. Lee HY, Lee SW, Kim HC, Ihm SH, Park SH, Kim TH. Cost-effectiveness analysis of hypertension screening in the Korea national health screening program. Korean Circ J. 2021; 51:610–622. PMID: 34085434.

6. Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019; 73:e35–66. PMID: 30827125.

7. Beyhaghi H, Viera AJ. Comparative cost-effectiveness of clinic, home, or ambulatory blood pressure measurement for hypertension diagnosis in US adults. Hypertension. 2019; 73:121–131. PMID: 30571548.

8. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011; 378:1219–1230. PMID: 21868086.

9. US preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for high blood pressure in adults: USPSTF reaffirmation recommendation state statement. JAMA. 2021; 325:1650–1656. PMID: 33904861.